AI

Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.

It follows the trust's recent work with GE Healthcare on creating an AI-driven command centre.

Both companies are ramping up the pace of their FDA clearances. 

To take full advantage of AI, organizations need the right team, clear metrics and goals, and the right expectations about real-world accuracy.

The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will focus on genomics, modeling and prediction of novel therapies and enhanced imaging. 

This includes a grant from the Innovate UK agency and investment from 24 Haymarket.

The round was led by Stanley Black & Decker's investment group, with strong support from Samsung Ventures.

Also: New competition exploring the use of AI and machine learning in the NHS opens today; Irish Life launches app with dacadoo for its clients; Elvie founder would consider moving the business "if it is looking like Brexit will have a negative impact".